Michael Barbella, Managing Editor05.14.24
ICON plc is losing its chief financial officer (CFO) later this year.
According to a news release, CFO Brendan Brennan will leave his role in the fourth quarter for a new opportunity outside of the contract research organization sector. Brennan has been CFO since 2012 and will remain with the company in his current role to ensure a smooth transition for his replacement. ICON has begun searching for Brennan's successor.
“On behalf of the ICON Board and Leadership Team, I want to thank Brendan for his strong contributions to ICON over his 18 years, including 12 years as CFO,” ICON CEO Steve Cutler said. “His leadership has contributed significantly to the growth of the company over an extended period and we wish him well with this new opportunity. We have commenced a search to identify our next CFO and will update on that process at the appropriate time. In the meantime, Brendan will continue to lead the ICON finance team as CFO.”
“It has been both a privilege and a pleasure to serve as ICON’s CFO for the last 12 years,” Brennan stated. “With ICON’s position, having successfully integrated PRA Health Sciences, and having been with ICON for 18 years, personally it feels like the right time for me to take on a new challenge in a new industry. I am proud of, and grateful for, my tenure with ICON and believe the company is well positioned for future growth and success.”
ICON plc is a healthcare intelligence and clinical research organization. From molecule to medicine, the firm advances clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. With headquarters in Dublin, Ireland, ICON employed approximately 41,100 employees in 106 locations in 53 countries as of Dec. 31, 2023.
According to a news release, CFO Brendan Brennan will leave his role in the fourth quarter for a new opportunity outside of the contract research organization sector. Brennan has been CFO since 2012 and will remain with the company in his current role to ensure a smooth transition for his replacement. ICON has begun searching for Brennan's successor.
“On behalf of the ICON Board and Leadership Team, I want to thank Brendan for his strong contributions to ICON over his 18 years, including 12 years as CFO,” ICON CEO Steve Cutler said. “His leadership has contributed significantly to the growth of the company over an extended period and we wish him well with this new opportunity. We have commenced a search to identify our next CFO and will update on that process at the appropriate time. In the meantime, Brendan will continue to lead the ICON finance team as CFO.”
“It has been both a privilege and a pleasure to serve as ICON’s CFO for the last 12 years,” Brennan stated. “With ICON’s position, having successfully integrated PRA Health Sciences, and having been with ICON for 18 years, personally it feels like the right time for me to take on a new challenge in a new industry. I am proud of, and grateful for, my tenure with ICON and believe the company is well positioned for future growth and success.”
ICON plc is a healthcare intelligence and clinical research organization. From molecule to medicine, the firm advances clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. With headquarters in Dublin, Ireland, ICON employed approximately 41,100 employees in 106 locations in 53 countries as of Dec. 31, 2023.